Table 3.
Mean | SE | CMW | Creatinine | Cystatin C | eGFR | n | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
r | P value | r | P value | r | P value | r | P value | ||||
Retinopathya | 1.54 | 0.08 | 0.293 | 0.0048 | 0.3303 | 0.0014 | 0.3576 | 0.0005 | − 0.2594 | 0.013 | 91 |
ABI | 1.07 | 0.01 | − 0.2916 | 0.0143 | − 0.2174 | 0.0706 | − 0.2288 | 0.0568 | 0.1549 | 0.2004 | 70 |
PWV | 1877.4 | 44.5 | 0.2476 | 0.0388 | 0.4008 | 0.0006 | − 0.3967 | 0.0007 | 0.2603 | 0.0295 | 70 |
MAsb | 0.303 | 0.05 | 0.367 | 0.0018 | 0.4672 | < 0.0001 | 0.3223 | 0.0065 | − 0.3777 | 0.0013 | 99 |
ABI, ankle-brachial pressure index; PWV, Brachial-ankle pulse wave velocity; CMW, C-mannosyl tryptophan.
aRetinopathy: Nonretinopathy, 1; Nonproliferative retinopathy, 2; Proliferative retinopathy, 3.
bMAs: Previous event(s) of macrovascular complications after the diagnosis of type 2 diabetes; Yes, 1; No, 0.